Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 32,000 shares at $85.35 ($2.7M) on 2021-07-01, disclosed to the SEC on 2021-07-01.
Open-market sale of $2.7M SWTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SWTX | SELL | 2025-02-12 | $1.6M | — | Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |